BeStock  
Stocks › Cannabis & Hemp › HROW

Harrow HROW

US equityMarket cap rank #3066Cannabis & Hemp
$30.41 −$1.72 (-5.35%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.30 -0.36%
Open$31.95
Prev close$32.13
Day range$30.32 – $32.43
Volume911.8K
Market cap$1.14B
P/E (TTM)–
Dividend yield–

HROW Stock News

Headlines matching Harrow or the HROW ticker, most recent first.

  • Leerink Partners Initiates Harrow(HROW.US) With Buy Rating, Announces Target Price $45Market news · 9 Sep 2026 · Direct mention
  • Craig-Hallum Maintains Harrow(HROW.US) With Buy RatingMarket news · 30 Sep 2026 · Direct mention
  • Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Caris Life Sciences, Inc. (CAI) PositiveTipRanks · 7 Aug 2026 · Direct mention
  • BTIG Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $63Market news · 26 Aug 2026 · Direct mention
  • Analysts' Top NA Picks: Harrow Health (HROW), Scribe Therapeutics Inc. (SCTX)TipRanks · 20 Aug 2026 · Direct mention
  • Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)TipRanks · 20 Aug 2026 · Direct mention
  • H.C. Wainwright Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $70Market news · 12 Aug 2026 · Direct mention
  • Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $88Market news · 11 Aug 2026 · Direct mention
  • Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Amentum Holdings, Inc. (AMTM) PositiveTipRanks · 11 Aug 2026 · Direct mention
  • B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Maintains Target Price $60Market news · 10 Aug 2026 · Direct mention
  • Craig-Hallum Maintains Harrow(HROW.US) With Buy Rating, Announces Target Price $59Market news · 13 Jul 2026 · Direct mention
  • H.C. Wainwright Remains a Buy on Harrow Health (HROW)TipRanks · 14 May 2026 · Direct mention
  • B. Riley Securities Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $60 NegativeMarket news · 14 May 2026 · Direct mention
  • Cantor Fitzgerald Maintains Harrow(HROW.US) With Buy Rating, Cuts Target Price to $88 NegativeMarket news · 13 May 2026 · Direct mention
  • Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Hims & Hers Health (HIMS) and ArriVent BioPharma, Inc. (AVBP)TipRanks · 12 May 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on HROW.

Sign in to join the discussion.

Scroll to Top